Benefits of Preemptive Living Kidney Transplantation: Reduced Rates of Cerebro‐Cardiovascular Events and Neoplasm Development
PEKT may confer a potential benefit in reducing the risk of CCVD and/or neoplasm development, although its advantages appear limited for other clinical outcomes.
Authors
- Hirotake Kodama (ORCID: https://orcid.org/0000-0002-5071-5149)
- Shingo Hatakeyama (ORCID: https://orcid.org/0000-0002-0026-4079)
- Tomonori Habuchi (ORCID: https://orcid.org/0000-0003-0998-4432)
- Norihiko Tsuchiya (ORCID: https://orcid.org/0000-0003-4242-2618)
- Wataru Obara (ORCID: https://orcid.org/0000-0003-2720-9640)
- Hayato Nishida (ORCID: https://orcid.org/0000-0002-8045-551X)
- Tomoko Hamaya
- Ayato Ito (ORCID: https://orcid.org/0000-0002-6573-3999)
- Mitsuru Saito (ORCID: https://orcid.org/0000-0003-1653-4309)
- Reiichi Murakami
- Chikara Οhyama (ORCID: https://orcid.org/0000-0003-1550-8379)
- Tomohiko Matsuura (ORCID: https://orcid.org/0000-0001-5360-1027)
- Hirofumi Tomita (ORCID: https://orcid.org/0000-0001-8149-3043)
- Hisao Saitoh
- Shinya Maita
Institutions
- Yamagata University (JP)
- Hirosaki University (JP)
- Iwate Medical University (JP)
- Akita University (JP)
- Kidney Research UK (GB)
- Iwate Prefectural Central Hospital (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1111/iju.70228
- Citations
- 2
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.97